S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in
CNSX:VIDA

Vidaroo Competitors

Add
Compare
Today's Range N/A
50-Day Range
$0.07
MA: $0.08
$0.11
52-Week Range N/A
Volume9,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Vidaroo (CNSX:VIDA) Vs. RIV, WLLW, LABS, KHRN, DN, and META

Should you be buying VIDA stock or one of its competitors? Companies in the industry of "drug manufacturers—specialty & generic" are considered alternatives and competitors to Vidaroo, including Canopy Rivers (RIV), Willow Biosciences Inc. (WLLW.TO) (WLLW), MediPharm Labs Corp. (LABS.TO) (LABS), Khiron Life Sciences Corp. (KHRN.V) (KHRN), Delta 9 Cannabis (DN), and Meta Growth Corp. (META.V) (META).

Vidaroo (CNSX:VIDA) and Canopy Rivers (TSE:RIV) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings and Valuation

This table compares Vidaroo and Canopy Rivers' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VidarooN/AN/AN/AN/AN/A
Canopy RiversC$15.44 million27.46C$-106,223,568.00C($0.76)-3.99

Vidaroo has higher earnings, but lower revenue than Canopy Rivers.

Analyst Recommendations

This is a breakdown of current recommendations for Vidaroo and Canopy Rivers, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vidaroo0000N/A
Canopy Rivers01002.00

Canopy Rivers has a consensus target price of C$4.00, suggesting a potential upside of 32.01%.

Profitability

This table compares Vidaroo and Canopy Rivers' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VidarooN/AN/AN/A
Canopy RiversN/AN/AN/A

Summary

Canopy Rivers beats Vidaroo on 1 of the 1 factors compared between the two stocks.

Vidaroo (CNSX:VIDA) and Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings and Valuation

This table compares Vidaroo and Willow Biosciences Inc. (WLLW.TO)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VidarooN/AN/AN/AN/AN/A
Willow Biosciences Inc. (WLLW.TO)C$2,360.0078,260.42C$-32,036,529.00C($0.28)-5.77

Vidaroo has higher earnings, but lower revenue than Willow Biosciences Inc. (WLLW.TO).

Analyst Recommendations

This is a breakdown of current recommendations for Vidaroo and Willow Biosciences Inc. (WLLW.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vidaroo0000N/A
Willow Biosciences Inc. (WLLW.TO)0000N/A

Willow Biosciences Inc. (WLLW.TO) has a consensus target price of C$2.75, suggesting a potential upside of 69.75%.

Profitability

This table compares Vidaroo and Willow Biosciences Inc. (WLLW.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VidarooN/AN/AN/A
Willow Biosciences Inc. (WLLW.TO)N/AN/AN/A

Summary

Willow Biosciences Inc. (WLLW.TO) beats Vidaroo on 1 of the 1 factors compared between the two stocks.

Vidaroo (CNSX:VIDA) and MediPharm Labs Corp. (LABS.TO) (TSE:LABS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings and Valuation

This table compares Vidaroo and MediPharm Labs Corp. (LABS.TO)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VidarooN/AN/AN/AN/AN/A
MediPharm Labs Corp. (LABS.TO)C$62.40 million1.45C$-41,458,230.00C($0.30)-2.19

Vidaroo has higher earnings, but lower revenue than MediPharm Labs Corp. (LABS.TO).

Analyst Recommendations

This is a breakdown of current recommendations for Vidaroo and MediPharm Labs Corp. (LABS.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vidaroo0000N/A
MediPharm Labs Corp. (LABS.TO)03102.25

MediPharm Labs Corp. (LABS.TO) has a consensus target price of C$1.98, suggesting a potential upside of 204.62%.

Profitability

This table compares Vidaroo and MediPharm Labs Corp. (LABS.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VidarooN/AN/AN/A
MediPharm Labs Corp. (LABS.TO)N/AN/AN/A

Summary

MediPharm Labs Corp. (LABS.TO) beats Vidaroo on 2 of the 2 factors compared between the two stocks.

Vidaroo (CNSX:VIDA) and Khiron Life Sciences Corp. (KHRN.V) (CVE:KHRN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings and Valuation

This table compares Vidaroo and Khiron Life Sciences Corp. (KHRN.V)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VidarooN/AN/AN/AN/AN/A
Khiron Life Sciences Corp. (KHRN.V)C$8.01 million10.31C$-39,493,921.00C($0.26)-2.09

Vidaroo has higher earnings, but lower revenue than Khiron Life Sciences Corp. (KHRN.V).

Analyst Recommendations

This is a breakdown of current recommendations for Vidaroo and Khiron Life Sciences Corp. (KHRN.V), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vidaroo0000N/A
Khiron Life Sciences Corp. (KHRN.V)0000N/A

Khiron Life Sciences Corp. (KHRN.V) has a consensus target price of C$1.20, suggesting a potential upside of 118.18%.

Profitability

This table compares Vidaroo and Khiron Life Sciences Corp. (KHRN.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VidarooN/AN/AN/A
Khiron Life Sciences Corp. (KHRN.V)N/AN/AN/A

Summary

Khiron Life Sciences Corp. (KHRN.V) beats Vidaroo on 1 of the 1 factors compared between the two stocks.

Delta 9 Cannabis (TSE:DN) and Vidaroo (CNSX:VIDA) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings for Delta 9 Cannabis and Vidaroo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Delta 9 Cannabis00014.00
Vidaroo0000N/A

Delta 9 Cannabis currently has a consensus price target of C$1.24, suggesting a potential upside of 121.43%.

Profitability

This table compares Delta 9 Cannabis and Vidaroo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Delta 9 CannabisN/AN/AN/A
VidarooN/AN/AN/A

Valuation & Earnings

This table compares Delta 9 Cannabis and Vidaroo's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$48.48 million1.18$-4,183,599.00C($0.04)-13.66
VidarooN/AN/AN/AN/AN/A

Vidaroo has lower revenue, but higher earnings than Delta 9 Cannabis.

Summary

Delta 9 Cannabis beats Vidaroo on 2 of the 2 factors compared between the two stocks.

Meta Growth Corp. (META.V) (CVE:META) and Vidaroo (CNSX:VIDA) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Profitability

This table compares Meta Growth Corp. (META.V) and Vidaroo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta Growth Corp. (META.V)N/AN/AN/A
VidarooN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings for Meta Growth Corp. (META.V) and Vidaroo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth Corp. (META.V)0000N/A
Vidaroo0000N/A

Valuation & Earnings

This table compares Meta Growth Corp. (META.V) and Vidaroo's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta Growth Corp. (META.V)C$60.96 million0.54$-50,412,840.00C($0.21)-0.66
VidarooN/AN/AN/AN/AN/A

Vidaroo has lower revenue, but higher earnings than Meta Growth Corp. (META.V).

Summary

Meta Growth Corp. (META.V) beats Vidaroo on 1 of the 1 factors compared between the two stocks.


Vidaroo Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
RIV
Canopy Rivers
0.8$3.03flatC$424.06 millionC$15.44 million-3.99Gap Down
WLLW
Willow Biosciences Inc. (WLLW.TO)
1.1$1.62flatC$184.70 millionC$2,360.00-5.77News Coverage
Gap Up
LABS
MediPharm Labs Corp. (LABS.TO)
1.4$0.65flatC$90.73 millionC$62.40 million-2.19Gap Down
KHRN
Khiron Life Sciences Corp. (KHRN.V)
0.9$0.55flatC$67.34 millionC$8.01 million-2.09News Coverage
DN
Delta 9 Cannabis
1.4$0.56flatC$57.14 millionC$48.48 million-13.66News Coverage
Gap Down
META
Meta Growth Corp. (META.V)
0.8$0.14flatC$36.69 millionC$60.96 million-0.66Gap Up
NRTH
48North Cannabis Corp. (NRTH.V)
0.6$0.29flatC$36.44 millionC$13.55 million-1.10Upcoming Earnings
CSI
(CSI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
IMCC
(IMCC)
0.0N/AN/A$0.00N/A0.00High Trading Volume
BAMM
28896
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATT
Abattis Bioceuticals
0.5N/AN/AC$0.00N/A0.00Gap Down
AGRA
Agraflora Organics International
1.4N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
GRIN
Grindrod Shipping
1.7N/AN/A$0.00N/A0.00High Trading Volume
SPR
Spirit AeroSystems
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.